13:50 , Jan 29, 2019 |  BC Innovations  |  Distillery Techniques

Assays and screens

TECHNOLOGY: Diagnostic assays; binding assays A peptide cleavage-based assay for detecting B. anthracis lethal factor could enable rapid diagnosis of anthrax infection. The micro-plate based assay involves detecting B. anthracis lethal factor by co-incubating plasma...
07:00 , Aug 16, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Anthrax Bacillus anthracis lethal factor In vitro studies suggest depsidones could help treat anthrax exposure. A high throughput screen for compounds that inhibit the...
08:00 , Feb 28, 2011 |  BC Week In Review  |  Clinical News

Dual Antibody Approach: Phase I started

IQ began a double-blind, placebo-controlled, dose-escalation Phase I trial to evaluate IQ-DAA in up to 32 healthy volunteers. IQ Therapeutics B.V. , Groningen, the Netherlands   Product: Dual Antibody Approach ( IQ-DAA )   Business:...
07:00 , Jul 29, 2002 |  BC Week In Review  |  Company News

University of Padova other research news

Researchers published in Nature a method for assaying LF metalloproteolytic activity using peptide substrates. The researchers suggested that these substrates could be used for high throughput screening of chemical libraries to identify specific LF inhibitors....